Skip to content

Dual Triggering in Patients With a High Immature Oocyte Rate

Dual Triggering With Gonadotropin-releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02813239
Enrollment
81
Registered
2016-06-24
Start date
2014-11-30
Completion date
2015-11-30
Last updated
2016-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

INFERTILITY

Keywords

IVF, Dual trigger, GnRH agonist, hCG, mature oocytes

Brief summary

In in vitro fertilization (IVF) cycles, even after adequate triggering, some patients present a high rate of immature oocytes retrieved after controlled ovarian stimulation. In vitro oocyte maturation is still an experimental technique, with poorer results than conventional IVF. For that reason improve in in vivo maturation could have a better impact on reproductive outcome.

Detailed description

Investigators performed an observational study analyzing the difference in the percentage of mature oocytes retrieved in patients with more than 50% immature oocytes in a previous IVF cycle triggered with human chorionic gonadotropin (rhCG) compared to the rate of mature oocytes retrieved in subsequent cycles, triggered with both gonadotropin-releasing hormone agonist (GnRHa) and (hCG). The main outcome measure was the number and percentage of mature oocytes retrieved.

Interventions

OTHERhCG

Oocyte maturation with hCG

OTHERhCG + GnRH agonist

Oocyte maturation with hCG + GnRH agonist

Sponsors

IVI Madrid
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI of 18-30 kg/m2 * Male factor required for ICSI

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Metaphase II rate1 dayNumber of metaphase II among total of recovered oocytes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026